# Dexrazoxane

NDC: 72205-247
Generic name: Dexrazoxane
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250326

FDA application: ANDA216748

## Active ingredients

- DEXRAZOXANE HYDROCHLORIDE: 250 mg/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-247"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-247
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7c01089-85f5-40aa-b679-f53a425b4d68